Novel strategies for relapsed and refractory acute myeloid leukemia.

Novel strategies for relapsed and refractory acute myeloid leukemia. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Novel strategies for relapsed and refractory acute myeloid leukemia. Abstract Text:

Anthony R Mato,Alicia Morgans,Selina M Luger,

PURPOSE OF REVIEW: Treatment for relapsed or refractory acute myeloid leukemia remains a major challenge for the leukemia community. Although several approaches have been tested in phase II study designs, few comparative data exist to guide treatment choices. We searched the recent literature in Medline, EMBASE and BIOSIS, and abstracts from the American Society of Hematology and American Society of Clinical Oncology published between 2005 and 2007. We reviewed each report to identify studies that used a phase II or III design and that included a majority of adults with non-M3 acute myeloid leukemia described as 'relapsed' or 'refractory'. RECENT FINDINGS: Several studies utilized novel cytotoxic chemotherapies, immunotherapies, epigenetic agents, and small molecule inhibitors. It is not possible to identify a single regimen or approach as the standard of care in relapsed and refractory acute myeloid leukemia. New and promising approaches are being explored, however. SUMMARY: Outcomes in patients treated for relapsed or refractory acute myeloid leukemia remain inadequate. Striking a balance between the treatment-related mortality associated with salvage therapies, response rates of salvage regimens, and the likelihood of long-term disease-free survival are critical in planning a treatment approach for the individual patient with relapsed or refractory acute myeloid leukemia.

Novel strategies for relapsed and refractory acute myeloid leukemia. Publishing Authors By Initials

AR Mato,A Morgans,SM Luger,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Novel strategies for relapsed and refractory acute myeloid leukemia. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Current opinion in hematology

VOLUME: 15

Page Numbers: 108-14

Journal Abbreviation: Curr. Opin. Hematol.

ISSN: 1065-6251

DAY: 27

MONTH: Mar

YEAR: 2008

Novel strategies for relapsed and refractory acute myeloid leukemia. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9430802

Novel strategies for relapsed and refractory acute myeloid leukemia. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Novel strategies for relapsed and refractory acute myeloid leukemia. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Novel strategies for relapsed and refractory acute myeloid leukemia.

AFFILIATION: Abramson Cancer Center and Division of Hematology and Oncology, Department of Internal Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Curr Opin Hematol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Novel strategies for relapsed and refractory acute myeloid leukemia Related Publications

• A beta-Hairpin Comprising the Nuclear Localization Sequence Sustains the Self-associated States of Nucleosome Assembly Protein 1.
• A charged and contoured surface on the nucleosome regulates chromatin compaction.
• A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
• Atomic properties of N(2)O(4) based on its experimental charge density.
• Clinical use of levo-arterenol during cyclopropane anesthesia.
• Comparative experimental electron density and electron localization function study of thymidine based on 20 K X-ray diffraction data.
• Effects of photochemically activated alkylating agents of the FR900482 family on chromatin.
• Evaluating hospital service quality from a physician viewpoint.
• Examination of intermolecular electronic interactions in the crystal structure of C60(CF3)12 by experimental electron density determination.
• Experimental charge density of L-alanyl-L-prolyl-L-alanine hydrate: classical multipole and invariom approach, analysis of intra- and intermolecular topological properties.
• Experimental electron density study of ethylene oxide at 100 K.
• Fast electron density methods in the life sciences--a routine application in the future?
• Histone chaperones in nucleosome eviction and histone exchange.
• Increased cerebral blood flow after leukapheresis for acute myelogenous leukemia.
• Modern aspects of cutaneous neurogenic inflammation.
• Neurophysiological and neurochemical basis of modern pruritus treatment.
• Neurophysiology of pruritus: cutaneous elicitation of itch.
• Novel strategies for relapsed and refractory acute myeloid leukemia.
• Oxygen application by a nasal probe prevents hypoxia but not rebreathing of carbon dioxide in patients undergoing eye surgery under local anaesthesia.
• Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance.
• Registries as a tool in evidence-based medicine: example of KIMS (Pfizer International Metabolic Database).
• Structure and function of nucleosome assembly proteins.
• Valproic Acid for the treatment of myeloid malignancies.
• Which patients with adult acute lymphoblastic leukemia should undergo a hematopoietic stem cell transplantation? Case-based discussion.
• [A very effective antiseptic in dermatology.]
• [Editorial: Venereal diseases]
• [Not Available.]
• [Radiation trials with lowered roentgen dosage in dermatoses.]
• [Skin thermometry and oscillometry in prognosis of leg ulcer.]
• [Symptoms and blood vessel changes in ulcus cruris.]